{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:01:51Z","timestamp":1790298111910,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-024-01050-6","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T23:41:40Z","timestamp":1729035700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sustainability of opioid agonist therapy programmes in Belarus, the Republic of Moldova, Tajikistan and Ukraine in the context of transition from Global Fund support during 2020\u20132023"],"prefix":"10.1186","volume":"21","author":[{"given":"Raminta","family":"Stuikyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Varentsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naimdzhon","family":"Malikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergii","family":"Dvoriak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myroslava","family":"Filippovych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisher","family":"Latypov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei","family":"Kralko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Iatco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"1050_CR1","unstructured":"World Health Organization (WHO). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence, 2019."},{"key":"1050_CR2","first-page":"2012","volume-title":"revision","author":"WHO, Unodc, UNAIDS technical guide","year":"2012","unstructured":"WHO, Unodc, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users \u2013,. revision. Geneva: World Health Organization; 2012. p. 2012."},{"key":"1050_CR3","unstructured":"WHO. Access to Hepatitis C Testing and Treatment For People Who Inject Drugs and People in Prisons \u2014 A Global Perspective. Policy Brief; Geneva, WHO, April 2019."},{"key":"1050_CR4","first-page":"2022","volume-title":"update","author":"WHO. Consolidated guidelines on HIV","year":"2022","unstructured":"WHO. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations -,. update. Geneva: WHO; 2022. p. 2022."},{"key":"1050_CR5","doi-asserted-by":"crossref","unstructured":"World Health Organization Model List of Essential Medicines \u2013 22nd List, 2021. Geneva: World Health Organization; 2021 (WHO\/MHP\/HPS\/EML\/2021.02).","DOI":"10.1530\/ey.19.13.1"},{"key":"1050_CR6","volume-title":"Global State of Harm Reduction 2022","author":"Harm Reduction International","year":"2022","unstructured":"Harm Reduction International. Global State of Harm Reduction 2022. London: Harm Reduction International; 2022."},{"key":"1050_CR7","unstructured":"Safranchuk I. Russia in a Reconnecting Eurasia. CSIS, September 30, 2016. Accessed on 17 September 2023 at https:\/\/www.csis.org\/analysis\/russia-reconnecting-eurasia"},{"key":"1050_CR8","unstructured":"Klyueva A, Tsetsura K. Strategic aspects of Russia\u2019s cultural diplomacy in Europe: Challenges and opportunities of the 21st Century, by Catellani, A., Trench, R. and Zerfass, A., Brussels: PIE Peter Lang, 2015."},{"key":"1050_CR9","unstructured":"Golichenko M, Elliott R. Drug laws and policies in four regions of Eurasia. Eastern and Central European and Central Asian Commission on Drug Policy (ECECACD). November 2021."},{"issue":"2","key":"1050_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.drugpo.2006.11.007","volume":"18","author":"A Sarang","year":"2007","unstructured":"Sarang A, Stuikyte R, Bykov R. Implementation of harm reduction in Central and Eastern Europe and Central Asia. Int J Drug Policy. 2007;18(2):129\u201335.","journal-title":"Int J Drug Policy"},{"key":"1050_CR11","unstructured":"Pates, R, Riley, D (Ed.). Harm Reduction in Substance Use and High-Risk Behaviour: International Policy and Practice. Addiction Press: ISBN: 978-1-405-18297-3, July 2012."},{"key":"1050_CR12","unstructured":"Stuikyte R. Perception of drugs in Central and Eastern Europe and Central Asia: overhaul needed. Eastern and Central European and Central Asian Commission on Drug Policy (ECECACD);2021."},{"key":"1050_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1477-7517-5-23","volume":"5","author":"R Elovich","year":"2008","unstructured":"Elovich R, Drucker E. On drug treatment and social control: Russian narcology\u2019s great leap backwards. Harm Reduct J. 2008;5:23. https:\/\/doi.org\/10.1186\/1477-7517-5-23.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1050_CR14","first-page":"33","volume":"6","author":"S Dvoryak","year":"2004","unstructured":"Dvoryak S. Evaluation of effectiveness of drug treatment programmes in Ukraine. Heroin Addict Relat Clin Probl. 2004;6(3):33\u20136.","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"1050_CR15","unstructured":"World Health Organization. The practices and context of pharmacotherapy of opioid dependence in central and Eastern Europe\u00a0(No. WHO\/MSD\/MSB\/04.1). World Health Organization;2004."},{"issue":"5","key":"1050_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.drugpo.2010.01.013","volume":"21","author":"A Latypov","year":"2010","unstructured":"Latypov A. Opioid substitution therapy in Tajikistan: Another perpetual pilot? Int J Drug Policy. 2010;21(5):407\u201310. https:\/\/doi.org\/10.1016\/j.drugpo.2010.01.013.","journal-title":"Int J Drug Policy"},{"key":"1050_CR17","unstructured":"Country reported OAT coverage for the Global AIDS Monitoring report was taken from the database of the Joint HIV\/AIDS Programme on HIV\/AIDS (UNAIDS) available at https:\/\/aidsinfo.unaids.org, accessed on 14 June 2023."},{"key":"1050_CR18","unstructured":"EMCDDA. 2022 Statistical Bulletin, accessed on 14 June 2023 at https:\/\/www.emcdda.europa.eu\/data\/stats2022_en [data for Latvia and Lithuania only as they were absent in the UNAIDS database]."},{"key":"1050_CR19","unstructured":"Hrytsenko Y. Fight for life: how Ukraine is fixing medical procurement and serving patients better [Internet]. Open Contracting Partnership. 2021. Accessed on 25 February 2024 at https:\/\/www.open-contracting.org\/2021\/02\/22\/fight-for-life-how-ukraine-is-fixing-medical-procurement-and-serving-patients-better\/"},{"key":"1050_CR20","unstructured":"Veljanov Z, Fazekas M. Efficiency gains from anti-corruption in pharmaceuticals procurement: Analysis of 9 countries across 3 continents.\u00a0GTI-WP\/2023:04, Budapest: Government Transparency Institute;2023."},{"issue":"9","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/heapol\/czac063","volume":"37","author":"HE Huffstetler","year":"2022","unstructured":"Huffstetler HE, Bandara S, Bharali I, Mcdade KK, Mao W, Guo F, Zhang J, Riviere J, Becker L, Mohamadi M, Rice RL, King Z, Farooqi ZW, Zhang X, Yamey G, Ogbuoji O. The impacts of donor transitions on health systems in middle-income countries: a scoping review. Health Policy Plan. 2022;37(9):1188\u2013202. https:\/\/doi.org\/10.1093\/heapol\/czac063.","journal-title":"Health Policy Plan"},{"key":"1050_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1744-8603-9-57","volume":"9","author":"LR Hirschhorn","year":"2013","unstructured":"Hirschhorn LR, Talbot JR, Irwin AC, et al. From scaling up to sustainability in HIV: potential lessons for moving forward. Glob Health. 2013;9:57. https:\/\/doi.org\/10.1186\/1744-8603-9-57.","journal-title":"Glob Health"},{"key":"1050_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2989\/16085906.2016.1138976","volume":"15","author":"G Oberth","year":"2016","unstructured":"Oberth G, Whiteside A. What does sustainability mean in the HIV and AIDS response? Afr J AIDS Res. 2016;15:1\u20139.","journal-title":"Afr J AIDS Res"},{"key":"1050_CR24","unstructured":"KFF & UNAIDS (2023). Donor Government Funding for HIV in Low- and Middle-Income Countries in 2022. Accessed on 17 September 2023 at https:\/\/files.kff.org\/attachment\/Report-Donor-Government-Funding-for-HIV-in-Low-and-Middle-Income-Countries-in-2022.pdf"},{"key":"1050_CR25","unstructured":"The Global Fund (2023). Projected transitions from Global Fund country allocations by 2028: projections by component. February 2023 update. Accessed on 10 December 2023 at: https:\/\/www.theglobalfund.org\/media\/9017\/core_projectedtransitionsby2028_list_en.pdf"},{"issue":"1","key":"1050_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-023-00919-2","volume":"21","author":"R Stuikyte","year":"2024","unstructured":"Stuikyte R, Varentsov I, Cook C, Dvoriak S. Measuring sustainability of opioid agonist therapy programs in the context of transition from global fund support. Harm Reduct J. 2024;21(1):1\u20132.","journal-title":"Harm Reduct J"},{"key":"1050_CR27","unstructured":"Iatco A. Republic of Moldova: Assessment of the sustainability of the opioid agonist therapy programme within the context of transition from donor support to domestic funding. Vilnius, Lithuania: Eurasian Harm Reduction Association (EHRA), 2020."},{"key":"1050_CR28","unstructured":"Kralko AA. Republic of Belarus: Assessment of the Sustainability of the Opioid Agonist Therapy Programme in the Context of Transition from Donor Support to Domestic Funding. EHRA, February-April 2020."},{"key":"1050_CR29","unstructured":"Dvoryak S, Zeziulin A. \u0423\u043apa\u0438\u043da: A\u043da\u043b\u0438\u0437 yc\u0442o\u0439\u0447\u0438\u0432oc\u0442\u0438 \u043fpo\u0433pa\u043c\u043c \u043fo\u0434\u0434ep\u0436\u0438\u0432a\u044e\u0449e\u0439 \u0442epa\u043f\u0438\u0438 a\u0433o\u043d\u0438c\u0442a\u043c\u0438 o\u043f\u0438o\u0438\u0434o\u0432 \u0432 \u043ao\u043d\u0442e\u043ac\u0442e \u043fepexo\u0434a o\u0442 \u0434o\u043dopc\u043ao\u0439 \u043fo\u0434\u0434ep\u0436\u043a\u0438 \u043a \u043da\u0446\u0438o\u043da\u043b\u044c\u043do\u043cy \u0444\u0438\u043da\u043dc\u0438po\u0432a\u043d\u0438\u044e. [in English: Analysis of the sustainability of opioid agonist maintenance therapy programme in the context of transition from donor support to domestic funding]. Kyiv, February-April 2020."},{"key":"1050_CR30","unstructured":"Latypov, A. Republic of Tajikistan: Assessment of the Sustainability of the Opioid Agonist Therapy Programme in the Context of Transition from Donor Support to Domestic Funding, EHRA, February-March 2020."},{"key":"1050_CR31","unstructured":"Kralko AA. Republic of Belarus: Reassessment of the sustainability of the opioid agonist therapy programme within the context of transition from donor support to domestic funding. EHRA: Vilnius, Lithuania, 2023."},{"key":"1050_CR32","unstructured":"Malikov N (2023). Tajikistan: Reassessing the sustainability of the opioid agonist therapy programme within the context of transition from donor support to domestic funding. EHRA: Vilnius, 2023."},{"key":"1050_CR33","unstructured":"Iatco A. Republic of Moldova: Reassessment of the sustainability of the opioid agonist therapy programme within the context of transition from donor support to domestic funding. EHRA: Vilnius, 2023."},{"key":"1050_CR34","unstructured":"Dvoryak, S, Filippovich, M. Ukraine: reassessment of the sustainability of the opioid agonist therapy programme within the context of transition from donor support to domestic funding. EHRA: Vilnius, 2023"},{"key":"1050_CR35","unstructured":"Stuikyte R, et al. Independent Review of the Ukraine\u2019s Transition Plan 2018\u20132021. PAS Center: Chisinau, Moldova, 2022. Accessed on 01 October 2023 at: https:\/\/www.phc.org.ua\/sites\/default\/files\/users\/user90\/Ukraine%20TP%20review_FINAL%202-15_2023_last.pdf"},{"key":"1050_CR36","unstructured":"World Bank. GDP growth (%): Ukraine. World Bank Databank. Accessed on 26 June 2024 at: https:\/\/data.worldbank.org\/indicator\/NY.GDP.MKTP.KD.ZG?locations=UA"},{"key":"1050_CR37","volume-title":"Failure to fund: the continued crisis for harm reduction funding in low- and middle-income countries","author":"L Serebryakova","year":"2021","unstructured":"Serebryakova L, et al. Failure to fund: the continued crisis for harm reduction funding in low- and middle-income countries. London: Harm Reduction International; 2021."},{"key":"1050_CR38","unstructured":"National statistical committee of the Republic of Belarus. Statistical bulletin No: 26\/170p \u00ab\u0427\u0438c\u043be\u043d\u043doc\u0442\u044c \u043dace\u043be\u043d\u0438\u044f \u043da 1 \u044f\u043d\u0432ap\u044f 2023 \u0433. \u0438 cpe\u0434\u043de\u0433o\u0434o\u0432a\u044f \u0447\u0438c\u043be\u043d\u043doc\u0442\u044c \u043dace\u043be\u043d\u0438\u044f \u0437a 2022 \u0433o\u0434 \u043fo Pec\u043fy\u0431\u043b\u0438\u043ae \u0411e\u043bapyc\u044c \u0432 pa\u0437pe\u0437e o\u0431\u043bac\u0442e\u0438\u0306, pa\u0438\u0306o\u043do\u0432, \u0433opo\u0434o\u0432, \u043foce\u043b\u043ao\u0432 \u0433opo\u0434c\u043ao\u0433o \u0442\u0438\u043fa\u00bb [in Russian. Population as of January 1, 2023 and the average annual population for 2022 in the Republic of Belarus by regions, districts, cities, urban settlements]. Belstat: Minsk, 2023. Accessed on 15 January 2024 at:\u00a0https:\/\/www.belstat.gov.by\/ofitsialnaya-statistika\/solialnaya-sfera\/naselenie-i-migratsiya\/naselenie\/statisticheskie-izdaniya\/index_67489\/"},{"key":"1050_CR39","unstructured":"National Bureau of Statistics of the Republic of Moldova. Moldova in figures. Statistical summary. Edition 2024: Chisinau, 2024. Accessed on 24 June 2024 at: https:\/\/statistica.gov.md\/files\/files\/publicatii_electronice\/Moldova_in_cifre\/2024\/Moldova_figures_2024.pdf"},{"key":"1050_CR40","unstructured":"State Statistics Service of Ukraine. Demographic situation in 2021. Macroeconomic indicator 12 June 2023. Kyiv, 2023. Accessed on 15 January 2024 at: https:\/\/stat.gov.ua\/en\/publications\/demographic-situation-2021."},{"key":"1050_CR41","unstructured":"Public Health Center of the MoH of Ukraine Official statistics on the opioid substitution treatment program in Ukraine. Kyiv. 2014\u20132023. 2023.\u00a0https:\/\/phc.org.ua\/kontrol-zakhvoryuvan\/zalezhnist-vid-psikhoaktivnikh-rechovin\/zamisna-pidtrimuvalna-terapiya-zpt\/statistika-zpt"},{"key":"1050_CR42","doi-asserted-by":"crossref","unstructured":"Zhao F, Benedikt C, Ward K. HIV and Allocative Efficiency in Eastern Europe and Central Asia. Tackling the World\u2019s Fastest-Growing HIV Epidemic. World Bank: Washington D.C, July 2020.","DOI":"10.1596\/978-1-4648-1523-2_intro"},{"key":"1050_CR43","doi-asserted-by":"crossref","unstructured":"Holt E. Difficult choices for people with HIV in the Donbas. The Lancet HIV. 2024 Jan 8.","DOI":"10.1016\/S2352-3018(24)00006-7"},{"key":"1050_CR44","unstructured":"Hurley R. At least 80 people have died in Crimea since Russian law banned opioid substitutes, says UN special envoy."},{"issue":"5","key":"1050_CR45","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/S2468-2667(22)00083-4","volume":"7","author":"FL Altice","year":"2022","unstructured":"Altice FL, Bromberg DJ, Dvoriak S, Meteliuk A, Pykalo I, Islam Z, Azbel L, Madden LM. Extending a lifeline to people with HIV and opioid use disorder during the war in Ukraine. Lancet Public Health. 2022;7(5):e482\u20134.","journal-title":"Lancet Public Health"},{"key":"1050_CR46","first-page":"35","volume":"1","author":"N Azzopardi-Muscat","year":"2023","unstructured":"Azzopardi-Muscat N, Zapata T, Kluge H. Moving from health workforce crisis to health workforce success: the time to act is now. ancet Regional Health-Europe. 2023;1:35.","journal-title":"ancet Regional Health-Europe"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01050-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T15:08:08Z","timestamp":1729091288000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01050-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4021071\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate.Not applicable as the manuscript does not report on, or involve the use of, any animal or human data or tissue. The results eminating from seven of the eight national level assessments summarised in the maniscript involved multistakeholder advisory groups (which included OAT expert clients) to inform the design, implementation and validation of the assessment reports. In 2023, Ukraine\u2019s re-assessment did not involve an advisory group; however, the results were summed up with partners and the report went through a review process including by the Public Health Centre under the Ministry of Health and the Global Fund. All experts being interviewed for the assessment purposes and participated in focus groups in the four countries signed informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as the manuscript does not contain data of any individual person in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}